WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.

Gary W. Procop, Member, CLSI

Gary W. Procop, MD, MS

Member, CLSI

Chief Executive Officer, American Board of Pathology

Gary W. Procop, MD, MS is the incoming Chief Executive Officer of the American Board of Pathology, effective January 1, 2022. He spent most of his career at the Cleveland Clinic where he held several leadership positions. He remains a Consulting Staff at Cleveland Clinic, and a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine.
Dr. Procop completed a Bachelor of Science at Eastern Michigan University, followed by an M.D. and M.S. at Marshall University School of Medicine. Residency training in Anatomic and Clinical Pathology training was completed at Duke University Medical Center, followed by a Clinical Microbiology Fellowship at the Mayo Clinic. He is a diplomat of the American Board of Pathology in Anatomic and Clinical Pathology, and Medical Microbiology. He is a Fellow of the American Academy of Microbiology, the College of American Pathologists, the American Society for Clinical Pathology, the Infectious Diseases Society of America, and the Royal Society of Tropical Medicine and Hygiene.
He has given more than 691 scientific presentations, and has 234 published manuscripts, 51 chapters, and has three books to his credit. He is a Member of the Board of Directors and the Chair of the Antifungal Subcommittee of the Clinical & Laboratory Standards Institute. He is also a Member of the Board of Directors of the American Board of Medical Specialties, and has held leadership positions in several other national Pathology and Microbiology organizations.
Major recognitions include the ASM BD Award for Research in Clinical Microbiology, the CAP Distinguished Patient Care Award, the Cleveland Clinic John Beach Hazard Teaching Award, the ASCP Mastership Designation, Case Western Reserve University School of Medicine Scholarship in Teaching Award, and the Belinda Yen-Lieberman, PhD, and James M. Lieberman, MD, Endowed Chair in Clinical Microbiology. His primary interests are developing and promoting best practices in laboratory testing, the practical applications of molecular diagnostic methods for the diagnosis and treatment of infections; infectious disease pathology; mycology and parasitology. He is currently working on a Masters of Education in Health Professions through Johns Hopkins University.